Medicines Evaluation Unit Ltd

meu.org.uk

The Medicines Evaluation Unit (MEU) Ltd, is one of the UK’s leading contract research organisations, a facility where commitment to excellence is paramount. Possessing extensive pharmaceutical, scientific and clinical expertise, within a state-of-the-art hospital-based research facility, allied with fast volunteer recruitment rates, enables MEU to offer clients positive clinical trial solutions. The MEU’s core skill area is in respiratory clinical trials, together with early phase exploratory studies. This is enhanced by the specialist support offered by collaboration with the University Hospital of South Manchester, and its extensive facilities.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

BUSINESS INSIGHTS

TIKOMED AND IQVIA ANNOUNCE A STRATEGIC COLLABORATION FOR THE DEVELOPMENT OF TIKOMED'S LEAD DRUG PLATFORM CANDIDATE ILB®

Tikomed | May 09, 2022

news image

Swedish biopharmaceutical company TikoMed AB and IQVIA announce a key strategic collaboration with the aim to accelerate the development of TikoMed's lead drug platform candidate ILB®, a broad-spectrum small molecule drug candidate with curative potential in a wide range of diseases driven by acute and chronic inflammation. The collaboration will support TikoMed's clinical development, regulatory and commercial strategies. IQVIA brings together deep therapeutic experti...

Read More

PHARMA TECH

SILVERBACK THERAPEUTICS AND ARS PHARMACEUTICALS ANNOUNCE MERGER

Silverback Therapeutics and ARS Pharmaceuticals | July 22, 2022

news image

Silverback Therapeutics, Inc. and ARS Pharmaceuticals, Inc. announced that the companies have entered into a definitive agreement under which ARS will merge with Silverback in an all-stock transaction. The combined company will focus on the potential regulatory approval and commercialization of neffy, ARS’s investigational epinephrine nasal spray for the treatment of Type I allergic reactions including anaphylaxis. The combined company is expected to have approximately $265M in cash, cash ...

Read More

JUBILANT RADIOPHARMA AND SOFIE BIOSCIENCES INK STRATEGIC COLLABORATION AGREEMENT TO FURTHER ADVANCE THE FIELD OF MOLECULAR IMAGING & THERAPEUTICS

SOFIE Biosciences, Inc. | November 05, 2020

news image

SOFIE Biosciences, Inc. ("SOFIE"), an established radiopharmaceutical supplier and worldwide radiopharmaceutical contract manufacturing organization, and Jubilant Radiopharma, a business division of Jubilant Pharma Limited, announced that both the organizations have entered into a strategic partnership. Under the terms of the partnership, Jubilant Pharma, via one of its wholly owned subsidiaries, with 25% of equity holding shall be a strategic partner to SOFIE, enabling SOFIE to contin...

Read More

PHARMACY MARKET

LUBRIZOL LIFE SCIENCE LAUNCHES ADVANCED, NATURAL NUTRACEUTICAL SOLUTION TO SUPPORT MENTAL AGILITY

Lubrizol Life Science | October 28, 2020

news image

Lubrizol Life Science Health (LLS Health) launches ASTAGILE™ microcapsules, its new sustainable, organic-certified, astaxanthin (Haematococcus pluvialis), microencapsulated with spirulina. The two ingredients have been uniquely combined in a patent-pending product designed to promote mental agility and support healthy ageing for young and senior adults. Astaxanthin is a carotenoid found in freshwater microalgae, and spirulina is a type of algae. Both have numerous health promoting effects....

Read More
news image

BUSINESS INSIGHTS

TIKOMED AND IQVIA ANNOUNCE A STRATEGIC COLLABORATION FOR THE DEVELOPMENT OF TIKOMED'S LEAD DRUG PLATFORM CANDIDATE ILB®

Tikomed | May 09, 2022

Swedish biopharmaceutical company TikoMed AB and IQVIA announce a key strategic collaboration with the aim to accelerate the development of TikoMed's lead drug platform candidate ILB®, a broad-spectrum small molecule drug candidate with curative potential in a wide range of diseases driven by acute and chronic inflammation. The collaboration will support TikoMed's clinical development, regulatory and commercial strategies. IQVIA brings together deep therapeutic experti...

Read More
news image

PHARMA TECH

SILVERBACK THERAPEUTICS AND ARS PHARMACEUTICALS ANNOUNCE MERGER

Silverback Therapeutics and ARS Pharmaceuticals | July 22, 2022

Silverback Therapeutics, Inc. and ARS Pharmaceuticals, Inc. announced that the companies have entered into a definitive agreement under which ARS will merge with Silverback in an all-stock transaction. The combined company will focus on the potential regulatory approval and commercialization of neffy, ARS’s investigational epinephrine nasal spray for the treatment of Type I allergic reactions including anaphylaxis. The combined company is expected to have approximately $265M in cash, cash ...

Read More
news image

JUBILANT RADIOPHARMA AND SOFIE BIOSCIENCES INK STRATEGIC COLLABORATION AGREEMENT TO FURTHER ADVANCE THE FIELD OF MOLECULAR IMAGING & THERAPEUTICS

SOFIE Biosciences, Inc. | November 05, 2020

SOFIE Biosciences, Inc. ("SOFIE"), an established radiopharmaceutical supplier and worldwide radiopharmaceutical contract manufacturing organization, and Jubilant Radiopharma, a business division of Jubilant Pharma Limited, announced that both the organizations have entered into a strategic partnership. Under the terms of the partnership, Jubilant Pharma, via one of its wholly owned subsidiaries, with 25% of equity holding shall be a strategic partner to SOFIE, enabling SOFIE to contin...

Read More
news image

PHARMACY MARKET

LUBRIZOL LIFE SCIENCE LAUNCHES ADVANCED, NATURAL NUTRACEUTICAL SOLUTION TO SUPPORT MENTAL AGILITY

Lubrizol Life Science | October 28, 2020

Lubrizol Life Science Health (LLS Health) launches ASTAGILE™ microcapsules, its new sustainable, organic-certified, astaxanthin (Haematococcus pluvialis), microencapsulated with spirulina. The two ingredients have been uniquely combined in a patent-pending product designed to promote mental agility and support healthy ageing for young and senior adults. Astaxanthin is a carotenoid found in freshwater microalgae, and spirulina is a type of algae. Both have numerous health promoting effects....

Read More